SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

Clinical trial NCT05628233 · COMPLETED

Trial details

NCT number: NCT05628233
Sponsor: Sensorion
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hearing Loss Ototoxic

Start date: 2022-12-30
Primary completion: 2025-04-16
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.